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Abstract 
We report 2 cases that were considered to be
neuro-Sweet disease. They initially manifested
with meningoencephalitis and no skin lesions,
and rapidly improved with corticosteroid thera-
py. In both cases, patients complained of menin-
gitic symptoms such as fever and headache, and
HLA-B54  and  -Cw1  turned  out  to  be  positive
over  the  clinical  course.  Cerebrospinal  fluid
analysis showed increased levels of lymphocytes
and protein. In case #1, fluid-attenuated inver-
sion  recovery  (FLAIR),  magnetic  resonance
imaging (MRI) and diffusion-weighted images
(DWI)  showed  high-intensity  signals  in  the
right dorsal medulla oblongata, bilateral dorsal
midbrain, and left thalamus. In case #2, FLAIR
and DWI showed high-intensity signals in the
bilateral  cerebellar  cortex  and  left  caudate
nucleus.  Symptoms  and  MRI  images  were
markedly improved in both cases after corticos-
teroid  pulse  therapy.  According  to  published
diagnostic criteria, these 2 cases were consid-
ered possible neuro-Sweet disease. These cases
suggest  that  the  combination  of  meningoen-
cephalitis and HLA specificity is important to
consider the possibility of neuro-Sweet disease,
even without skin lesions.
Introduction
Sweet disease is a systemic disease charac-
terized by fever, peripheral blood leukocytosis,
and tender, elevated, erythematous plaques on
the face, extremities, and elsewhere.1,2 Sweet
disease with central nervous system involve-
ment has been reported as neuro-Sweet dis-
ease (NSD).3 Cases of NSD presenting with
meningoencephalitis have been reported, but
skin  symptoms  usually  precede  or  coincide
with neurological symptoms in most cases, and
the neurological symptoms rarely precede the
cutaneous symptoms. We report 2 patients who
initially  presented  with  meningoencephalitis
and  in  whom  NSD  was  suspected  from  the
results of HLA typing, although no skin symp-
toms were observed. 
Case #1
The patient was a 51-year old woman whose
chief  complaints  were  an  unsteady  gait,
headache,  and  fever.  Her  family  history  was
unremarkable. She had undergone surgery for
a benign right femoral tumor at the age of 42,
and had been suspected of having a brainstem
glioma (which subsided after steroid therapy)
at the age of 44. Eight days before admission to
our  department,  she  started  to  develop  a
headache on awakening, followed by dizziness,
an unsteady gait, and double vision. The next
day, she had a fever of 39-40°C, and visited a
local clinic. Since brain MRI showed a brain-
stem lesion, she was admitted to our hospital.
On  admission,  her  temperature  was  37.2°C,
and blood pressure 122/76 mmHg. No remark-
able  features  were  observed  in  heart,  lungs,
and  abdomen.  There  were  no  skin  lesions.
Needle  reaction  was  negative.  Neurological
examination  showed  a  clear  consciousness,
horizontal  nystagmus  on  lateral  gaze  to  the
right, an unpleasant sensation on the right side
of the face, and dysarthria. Barré’s sign was
positive  in  the  right  upper  limb,  and
Mingazzini’s  sign  was  positive  in  the  right
lower  limb.  Tendon  reflexes  were  somewhat
increased  in  the  right  arm  and  leg,  but  no
pathological reflexes were noted. The finger-to-
nose test was poorly performed on the right
side. She had a cerebellar ataxic gait, and could
not  perform  tandem  gait.  No  abnormalities
were seen in the autonomic nervous system.
There was no nuchal rigidity or Kernig’s sign. 
Laboratory findings on admission were: ery-
throcyte  sedimentation  rate  25  mm/h,
increased  white  blood  cell  count  9,000/mL
(77.9% neutrophils), and hepatic dysfunction
with  elevated  AST  (123  IU/L)  and  ALT  (397
IU/L). Serum antibody titers against various
viruses indicated past exposure to them. Anti-
nuclear  antibody  was  negative.  ACE  and
lysozyme levels were within normal limits. The
s-IL-2R  level  was  272  U/mL  (standard  value
145-519 U/mL). The Mantoux test was nega-
tive. Cerebrospinal fluid examination showed
a normal initial pressure, cell count of 129/mL
(80 monocytes and 49 polymorphs), protein of
72  mg/dL,  and  glucose  of  53  mg/dL  (fasting
blood glucose 108 mg/dL). The IL-6 level was
5.1 pg/mL, the myelin basic protein level was
normal, and the oligoclonal IgG band was neg-
ative. FLAIR and diffusion-weighted brain MRI
showed high signal intensity areas in the right
dorsal medulla oblongata, ventral pons (pre-
dominantly  on  the  left  side),  bilateral  mid-
brain, and left hypothalamus, with no contrast
enhancement (Figure 1A and B). ADC values
were increased in these areas (Figure 1C).
After  admission,  multiple  demyelinating
lesions  were  observed  mainly  in  the  brain-
stem,  strongly  suggesting  a  non-infectious
autoimmune disease; therefore, steroid pulse
therapy  with  1  g/day  of  methylprednisolone
(mPLS) for three days was started on the day
of  admission.  Thereafter,  the  neurological
symptoms gradually improved, and the cere-
brospinal  fluid  cell  count  decreased.  MRI
showed shrinkage of the high-density areas.
On Day 12 after admission, she was found to
be negative for HLA-B51 and positive for HLA-
B54 and -Cw1. After 3 courses of steroid pulse
therapy, she was switched to 30 mg/day of oral
PSL on the Day 19 after admission, which was
then  tapered.  A  brain  MRI  on  Day  20  after
admission  showed  the  disappearance  of  the
lesions (Figure 1D). The patient experienced
no disease recurrence, and was discharged on
Day 21 after admission. Subsequently, she was
followed-up as an outpatient, and steroid ther-
apy was discontinued three months later. At
present, two years after onset, she shows no
recurrence of symptoms or skin lesions.
Case #2 
The patient was a 42-year old woman whose
complaint was of headache and fever. The fam-
ily  history  showed  that  her  grandfather  had
died of pancreatic cancer. She had a history of
surgery for acute appendicitis at the age of 16.
She presented with common cold-like symp-
toms, such as headache and fever, two weeks
Correspondence: Yasuhiro Manabe, Department
of  Neurology,  National  Hospital  Organization
Okayama Medical Center, 1711-1 Tamasu Kitaku,
Okayama, Okayama 701-1192, Japan.
Tel. +86.294.9911 - Fax: +86.294.9255.
E-mail: ymanabe@okayama3.hosp.go.jp
Key  words:  neuro-Sweet  disease,  meningoen-
cephalitis, neuro-neutrophilic disease.
Received for publication: 4 August 2011.
Revision received: 20 October 2011.
Accepted for publication: 17 January 2012.
This work is licensed under a Creative Commons
Attribution NonCommercial 3.0 License (CC BY-
NC 3.0).
©Copyright G. Makimoto et al., 2012
Licensee PAGEPress srl, Italy
Neurology International 2012; 4:e5
doi:10.4081/ni.2012.e5
[page 20] [Neurology International 2012; 4:e5]before admission to our department, and had
visited a local clinic, where she had been pre-
scribed  antibiotics  (details  are  unknown).
Since the symptoms did not improve, she was
admitted to our hospital. On admission, her
temperature was 39.3°C, and blood pressure
120/72 mmHg. There were no remarkable fea-
tures in heart, lungs, or abdomen. There were
no skin lesions. The needle reaction was nega-
tive.  Neurological  examination  revealed  the
disturbance of consciousness (JCSI-2). There
were no cranial nerve, motor, or sensory abnor-
malities.  The  tendon  reflexes  were  normal,
and no pathological reflexes were noted. She
had a cerebellar ataxic gait, and could not per-
form tandem gait. The autonomic nervous sys-
tem showed no abnormalities. Nuchal rigidity
was noted, but Kernig’s sign was negative.
Laboratory  examination  on  admission
revealed a white blood cell count of 5300/mL,
and  no  biochemical  abnormalities.  Serum
antibody titers against various viruses indicat-
ed past exposure to them. Anti-nuclear anti-
body was negative. Cerebrospinal fluid exami-
nation showed a normal initial pressure, cell
count of 332/mL (328 monocytes and 4 poly-
morphs), protein of 371 mg/dL, and glucose of
28 mg/dL (fasting blood glucose, 117 mg/dL).
Brain MRI revealed no abnormal signal.
After admission, she was initially suspected
of having bacterial or viral meningitis, and was
started on an intravenous drip infusion of cef-
triaxone (4 g/day) and acyclovir (750 mg/day).
However, the fever did not improve, and the
level of consciousness deteriorated to JCS 10
or higher. On Day 12 after admission she was
found to be negative for HLA-B51 and positive
for HLA-B54 and -Cw1, which suggested neuro-
Sweet disease. The next day, she was started
on steroid pulse therapy (1 g/day of mPLS for 3
days). On Day 13 after admission, FLAIR and
diffusion-weighted  brain  MRI  showed  high-
signal-intensity areas in the bilateral cerebel-
lar  hemispheres  and  left  caudate  nucleus
(Figure 2A,B). She received a total of three
courses of steroid pulse therapy. Since her con-
sciousness level and neurological symptoms,
including  right  hemiparesis  and  ataxic  gait,
gradually  improved,  she  was  discharged  on
Day 27 after admission. FLAIR brain MRI find-
ings observed on Day 13 after admission had
disappeared on Day 27 after admission (Figure
2C). Subsequently, she was followed-up as an
outpatient.  At  present,  one  year  after  onset,
only slight paralysis of the right arm and leg
remains, and she has experienced no recur-
rence of symptoms or skin lesions.
Discussion
The  two  patients  initially  presented  with
meningitis,  but  had  no  skin  lesions.  They
responded well to steroid therapy, resulting in
a rapid improvement of the clinical symptoms
and  imaging  findings.  During  their  clinical
course, they were found to be positive for HLA-
B54 and -Cw1. Since Patient #1 had a history of
steroid  therapy  for  similar  symptoms  eight
years previously, a demyelinating disease was
suspected.  However,  this  was  excluded
because  the  clinical  and  laboratory  findings
were atypical in that the cerebrospinal fluid
cell count increased, the lesions were confined
to  the  brainstem,  no  contrast  enhancement
was observed, and a high fever of 39-40°C was
noted. Although she had no skin lesions, she
responded to steroids. Therefore, in view of the
diagnostic  criteria  for  NSD  proposed  by
Hisanaga et al.3 in 2005, she was considered to
have possible NSD. Patient #2 presented with
clinical features of meningitis on admission,
but she was resistant to antibiotics and antivi-
ral drugs. This patient was also considered to
have possible NSD, because she responded to
steroids,  and  the  symptoms  disappeared
except  for  slight  hemiparesis  and  also  met
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Figure 1. Brain MRI on admission in Case #1. Serial images of axial fluid-attenuated
inversion recovery magnetic resonance imaging  and diffusion-weighted images  showing
high-intensity signals in the right dorsal medulla oblongata, bilateral dorsal midbrain,
and left thalamus (A and B, arrows). Apparent diffusion coefficient values were increased
(C, arrows). Follow-up FLAIR images at 20 days after admission showed that the high-
intensity signals in the right dorsal medulla oblongata, bilateral dorsal midbrain, and left
thalamus were markedly decreased (D).other diagnostic criteria for NSD. NSD often
initially  presents  with  skin  symptoms:
Hisanaga et al.4 reported that 27 of 29 NSD
patients  initially  presented  with  cutaneous
symptoms or both cutaneous and neurological
symptoms, and that only 2 initially presented
with neurological symptoms Our search of the
literature found that 39 patients with NSD had
developed meningitis,5-12 but only 2 of them
had initially presented with neurological symp-
toms,  suggesting  that  such  a  case  is  rare
(Table 1). In cases reported by Hisanaga et al.4
and Kokubo et al.,7 skin rashes appeared 29
and 64 months, respectively, after the onset of
NSD;  the  diagnosis  of  NSD  was  established
based on pathological findings. Their reports
suggest that skin rashes may develop in our 2
surviving patients during their future clinical
course.
Since there are currently no specific mark-
ers for NSD, it is difficult to differentiate NSD
from infectious meningoencephalitis, multiple
sclerosis,  neuro-  Behçet  disease  (NBD),
Hashimoto’s  encephalopathy,  Sjögren’s  syn-
drome,  CNS  lupus,  sarcoidosis,  non-herpetic
limbic encephalitis, postviral encephalopathy,
brain tumor, etc., before the results of HLA typ-
ing are known. In particular, the differentia-
tion of NSD from NBD often poses a difficult
diagnostic  problem.  These  two  diseases  are
considered to be closely related in that they are
exudative immune diseases associated with a
state of immune sensitivity, such as neutrophil
hyperfunction.4 NSD is characterized by: i) lit-
tle gender preponderance unlike the marked
male preponderance of NBD; ii) age at onset
between 30 and 70 years; iii) frequent recur-
rence  but  showing  a  favorable  response  to
steroids  and  being  less  likely  to  result  in
sequelae; and iv) being almost always positive
for HLA-Cw1 and frequently positive for HLA-
B54, unlike the high positive rate (about 80%)
of HLA-B51 in NBD.13 In addition, NBD has a
predilection for the basal ganglia and brain-
stem,  whereas  NSD  presents  with  abnormal
signal intensity areas at various sites of the
central nervous system at similar frequencies,
and these signal abnormalities often resolve
with the relief of symptoms. Furthermore, it is
thought that the lesions of NBD are often dis-
tributed ventrally in the brainstem correspon-
ding to the clinical symptoms, whereas those
of NSD are frequently located in the dorsal por-
tion  of  the  brainstem  (mainly  the  mesen-
cephalic tegmentum). The lesions of both dis-
eases present a low intensity on T1-weighted
images  and  high  intensity  on  T2/FLAIR
images, but the lesions of NBD and NSD often
present with an isointensity and a high inten-
sity,  respectively.  Moreover,  acute  active
lesions  of  NBD  are  often  enhanced  with
gadolinium,  but  NSD  lesions  are  not.4 Both
Patients #1 and Patient #2 were middle-aged
women,  and  they  responded  well  to  steroid
therapy with virtually no sequelae, suggesting
that they had NSD. Also, the presence of high-
intensity  areas  in  the  dorsal  portion  of  the
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Figure 2. Brain magnetic resonance imaging  13 days after admission in Case #2. Serial
images of axial fluid-attenuated inversion recovery and diffusion-weighted images show-
ing high-intensity signals in the bilateral cerebellar cortex and left caudate nucleus (A and
B, arrows). Follow-up fluid-attenuated inversion recovery images at 27 days after admis-
sion showed that the high-intensity signals in the bilateral cerebellar cortex and left cau-
date nucleus were markedly decreased (C).
Table 1. Clinical features of acute meningoencephalitis as the initial manifestation in neuro-Sweet disease. 
Case Age/sex Symptoms MRI findings Time of dermal Treatment Outcome Author
events after report 
onset year, ref.
1 32/M Disorientation, Basal ganglia, brain stem, 29 months Steroid Favorable Hisanaga et al.
fever cerebral white matter 19994
2 34/M Dysarthria, hemiparesis Basal ganglia, brain stem, 64 months Steroid Favorable Kokubo et al. 20067
cerebral white matter
3 51/F Dizziness, headache, Brain stem, thalamus Steroid Favorable Our case #1
fever 2011
4 42/F Headache, fever Basal ganglia, cerebellum Steroid Favorable Our case #2
2011medulla oblongata of Patient #1 on FLAIR and
diffusion-weighted images was suggestive of
NSD. In addition, an increase in the apparent
diffusion  coefficient  was  observed  in  the
lesions,  suggesting  reversible  extracellular
edema.  Conversely,  an  HLA-B54-positive
patient was conclusively diagnosed with NBD
by skin biopsy.14 Therefore, not only HLA typ-
ing but also clinical symptoms and histopatho-
logical examination are important for the dif-
ferentiation  between  NBD  and  NSD,  and
patients should be carefully followed-up, espe-
cially for the development of skin rashes.
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